Abstract

This manuscript describes the evaluation of anti-infective potential in vitro of organic extracts from nine sponges, one ascidian, two octocorals, one bryozoan, and 27 seaweed species collected along the Brazilian coast. Antimicrobial activity was tested against Staphylococcus aureus (ATCC 25923), Enterococcus faecalis (ATCC 29212), Pseudomonas aeruginosa (ATCC 27853), Escherichia coli (ATCC 25922) and Candida albicans (ATCC 10231) by the disk diffusion method. Antiprotozoal activity was evaluated against Leishmania braziliensis (MHOM/BR/96/LSC96-H3) promastigotes and Trypanosoma cruzi (MHOM/BR/00/Y) epimastigotes by MTT assay. Activity against intracellular amastigotes of T. cruzi and L. brasiliensis in murine macrophages was also evaluated. Antiviral activity was tested against Herpes Simplex Virus type 1 (HSV-1, KOS strain) by the plaque number reduction assay (IC50). Cytotoxicity on VERO cells was evaluated by the MTT assay (CC50). The results were expressed as SI = CC50/IC50. The most promising antimicrobial results were obtained against S. aureus and C. albicans with Dragmacidon reticulatum. Among the seaweeds, only Osmundaria obtusiloba showed moderate activity against P. aeruginosa. Concerning antiprotozoal activity, Bugula neritina, Carijoa riseii, Dragmaxia anomala and Haliclona (Halichoclona) sp. showed the most interesting results, mainly against extracellular promastigote forms of L. braziliensis (66, 35.9, 97.2, and 43.6% inhibition, respectively). Moreover, six species of seaweeds Anadyomene saldanhae, Caulerpa cupressoides, Canistrocarpus cervicornis, Dictyota sp., Ochtodes secundiramea, and Padina sp. showed promising results against L. braziliensis (87.9, 51.7, 85.9, 93.3, 99.7, and 80.9% inhibition, respectively), and only Dictyota sp. was effective against T. cruzi (60.4% inhibition). Finally, the antiherpes activity was also evaluated, with Haliclona (Halichoclona) sp. and Petromica citrina showing the best results (SI = 11.9 and SI > 5, respectively). All the active extracts deserve special attention in further studies to chemically characterize the bioactive compounds, and to perform more refined biological assays.

Highlights

  • Marine natural products represent an immeasurable potential source of new drugs with diverse and often unique structures [1], and diverse biological properties, such as antiviral [2], antibacterial [3], antiprotozoal [4,5,6], antifungal [7], cytotoxic [8,9,10] and antitumoral activities [11,12] have been reported

  • This paper describes the in vitro antimicrobial, antiprotozoal and antiviral evaluation of organic extracts and fractions from 13 marine invertebrate species (nine sponges, one ascidian, two octocorals, and one bryozoans (Table 1), and 27 seaweeds species [sixteen Rhodophyta (59.2%), seven

  • Previous studies performed by Veiga-Santos et al [5] and Machado et al [37] showed that lipophilic extracts from L. dendroidea collected from the southeastern coast of Brazil strongly inhibited the growth of T. cruzi and L. amazonensis

Read more

Summary

Introduction

Marine natural products represent an immeasurable potential source of new drugs with diverse and often unique structures [1], and diverse biological properties, such as antiviral [2], antibacterial [3], antiprotozoal [4,5,6], antifungal [7], cytotoxic [8,9,10] and antitumoral activities [11,12] have been reported. The results suggest these are a rich source of natural compounds with cytotoxic properties [23]. In attention to the human constant need for new drugs and therapies in the present work, we performed an anti-infective (antibacterial, antifungal, antiprotozoal and antiviral) screening of 95 different extracts and fractions from 13 marine invertebrates collected from the southern Brazilian coast, and 27 seaweeds from the northeastern Brazilian coast

Results and Discussion
Marine Invertebrates
Marine Seaweeds
Collection of the Marine Organisms
Preparation of the Extracts
Antibacterial and Antifungal Assays
Antileishmanial and Antitrypanosomal Activities
Virus and Cell Line
Cytotoxicity Assay
Viral plaque Number Reduction Assay
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call